Primary Sclerosing Cholangitis and Multiple Autoimmune Disorders in a Patient With Down Syndrome

Raiti S. , Lifshitz F. , Trias E. , Sigman B. Study of carbohydrate metabolism. Acta Endocrinol. 1974;76:506-512.

Burgio GR , Ugazio AG Immunity in Down's Syndrome. Eur J Pediatr. 1978; 127:293-294. Letter.

Ruch W. , Schurmann K. , Gordon P. , et al. Coexistent coeliac disease, Graves' disease and diabetes mellitus type 1 in a patient with Down syndrome. Eur J Pediatr. 1985;144:89-90.

DuViver A. , Munro D. Alopecia areata, autoimmunity and Down's syndrome. BMJ. 1975;1:191-192.

McCulloch AJ , Ince PG , Kendall-Taylor P. Autoimmune chronic active hepatitis in Down's syndrome. J Med Gen. 1982 ;19:232-234.

Balistreri WF , Bove KE Primary sclerosing cholangitis and similar hepatobiliary lesions. In: Balistreri WF , Vanderhoof JA , eds. Pediatric Gastroenterology and Nutrition. Aspen Seminars on Pediatric Disease. Vol 4. London, England: Chapman and Hall; 1990:196-236.

O'Donnell B. , Kelly P. , Dervan P. , Powell FC Generalized elastosis perforans in Down's syndrome. Clin Exp Dermatol. 1992;17:31-33.

Sherlock S. , Dooley J. Sclerosing cholangitis In: Sherlock S , Dooley J , eds. Diseases of the Liver and Biliary System. 9th ed. Oxford, England: Blackwell Scientific Publications ; 1993:249-259.

Chapman RW , Varghese Z. , Gaul R. , et al. Association of primary sclerosing cholangitis with HLA-B8. Gut. 1983;24:38-41.

Donaldson PT , Farrant JM , Wilkinson M. , et al. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology. 1991;13:129-133.

Bodenheimer HC , LaRusso NF , Thayer WR Jr, et al. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology. 1983;3: 150-154.

El-Shabrawi M. , Wilkinson ML , Portmann B. , et al. Primary sclerosing cholangitis in childhood. Gastroenterology. 1987;92:1226-1235.

Mieli-Vergani G. , Lobo-Yeo A, McFarlane IG, etal. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology . 1989;9:198-203.

Zauli D. , Schrumpf E. , Crespi C. , et al. An autoantibody profile in primary sclerosing cholangitis. J Hepatol. 1987;5:14-18.

Mulder Ahl , Horst G. , Haagsma EB , et al. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver disease. Hepatology. 1993 ;17:411-417.

Duerr RH , Targan SR , Landers CJ , et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1991;100:1385-1391.

Das KM , Jeffers L. , Squillante L. , et al. The presence of circulating antibodies in patients with sclerosing cholangitis against an epitope(s) on MR 40 000 protein shared by colon and bile duct epithelial cells. Gastroenterology. 1989;96:A590.

Mehal WZ , Hubscher SG , Wordsworth BP , et al. Immunogenetic factors in the clinical course of primary sclerosing cholangitis. Gastroenterology. 1993;104: A953.

Lo SK , Chapman RW , Dooley JS , Fleming KA Aberrant HLA-DR antigen expression by bile duct epithelium in primary sclerosing cholangitis is downregulated by ursodeoxycholic acid. Gastroenterology . 1993;104:A963

Thompson HH , Pitt HA , Lewin KJ , Long-mire WP Jr. Sclerosing cholangitis and histiocytosis X. Gut. 1984;25:526-530.

Ugazio AG , Maccario R. , Notarangelo LD , Burgio GR Immunology of Down syndrome: a review. Am J Med Gen. 1990;7:204-212.

Quigley Emm , LaRusso NF , Ludwig J. , et al. Familial occurence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1983;85:1160-1165.